NK cells and CTL: Opposite sides of the same coin

Chemical Immunology

Volumn 64, Issue , 1996, Pages 146-163

  Valiante, Nicholas M ^a   Parham, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CYTOTOXIC LYMPHOCYTE; DNA POLYMORPHISM; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

EID: 0029841984     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319340     Document Type: Review

References (81)

1. Govearts H: Cellular antibodies in kidney homotransplantation, J Immunol 1960;85;516.
2. Perlman P, Holm G: Cytotoxic effect of lymphoid cells in vitro Adv Immunol 1969;11:117.
3. Cerottini JC, Brunner KT: Cell-mediated cytotoxicity. allograft rejection and tumor immunity. Adv Immunol 1974;18:67.
4. Zinkernagel RM, Doherty P: Immunological surveillance against altered self components by sensitized T lymphocytes in lymphochoriomeningitis. Nature 1974;251:547
5. Zinkernagel RM, Doherty PC: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis with a syngenic or semiallogeneic system. Nature 1974;248:701.
6. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988;334: 395.
7. Herberman RB, Nunn MF, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975; 16:230.
8. Kiessling R, Klein E, Wigzell H: 'Natural' killer cells in the mouse. I Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112.
9. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47:187.
10. Moingeon P, Jitsukawa S, Faure F, et al: A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature 1987;325:723.
11. Dianzam U, Zarcone D, Pistoia V. et al: CD8+ /CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors. Eur J Immunol 1989;19:1037.
12. Lanier LL, Phillips JH, Hackett J, Tutt M, Kumar V. Natural killer cells: Definition of a cell type rather than a function. J Immunol 1986;137:2735.
13. Lanier LL, Le AM, Civin CI, Loken M, Phillips JH: The relationship of CD16 (leu-11) and leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 1986;136:4480.
14. Perussia B, Fanning V, Trinchieri G: A human NK and K cell subset shares with cytotoxic T cell expression of the antigen recognized by antibody OKTS J Immunol 1983;131:223.
15. Kehri JH, Dukovich M, Whalen G, Katz P, Fauci AS, Greene WC: Novel interleukin-2 (IL-2) receptor appears to mediate IL-2 induced activation of natural killer cells. J Clin Invest 1988;81: 200.
16. London L, Perussia B, Trinchieri G: Induction of proliferation in vitro of resting human natural killer cells: Expression of surface activation antigens. J Immunol 1985;134:718.
17. Anegon I, Cuturi MC, Trinchieri G, Perussia B: Interaction of Feγ receptor (CD16) induces transcription of IL-2 (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988;167:452.
18. Doherty PC: Cell-mediated cytotoxicity. Cell 1993;75:607.
19. Rouvier E, Luciani MF, Golstein P: Fas involvement in calcium-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195.
20. Arase H, Arase N, Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995;181:1235.
21. Weigent DA, Langford MP, Fleishman WR, Stanton GJ: Enhancement of natural killing activity by different types of interferon. in Khan A, Hill NO (eds). Human Lymphokines. New York, Academic Press, 1982, p 539.
22. Smith KA: Interleukin-2: Inception, impact and implications. Science 1988;240:1169.
23. Chehimi J, Valiante NM, D'Andrea A, et al: Enhancing effect of natural killer cell stimulatory factor (NKSF/IL-12) on cell-mediated cytotoxicity against tumor-derived and virally-infected cells. Eur J Immunol 1993;23:1826.
24. Kobayashi M, Fitz L, Ryan M, et al: Identification and purification of natural killer cell stimulatory factor, a cytokine with multiple biologic effects on human lymphocytes J Exp Med 1988;170:827.
25. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251.
26. Trinchieri G, Valiante N: Receptors for the Fc fragment of IgG on natural killer cells. Nat Immun 1993;12:218.
27. Shinkai Y, Rathbun G, Lam KP, et al: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement Cell 1992;68:855
28. Hackett J, Bosma GC, Bosma MJ, Bennett M, Kumar V: Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci USA 1986;83: 3427.
29. Lanier LL, Spits H, Phillips JH: The developmental relationship between NK cells and T cells. Immunol Today 1992;13:392.
30. Lanier LL, Yu G, Phillips JH. Co-association of CD3 zeta with a receptor (CD16) for IgGFc on human natural killer cells. Nature 1989;342:803.
31. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF: CDS-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature 1989;341:159
32. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL: Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CDS epsilon and delta proteins. J Exp Med 1992;175:1055.
33. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH: Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994;180:569.
34. Rodewald HR, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL: A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells Cell 1992;69:139.
35. Gumperz JE, Parham P. The enigma of the natural killer cell. Nature 1995;378-245.
36. Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237
37. Parham P, Adams EJ, Arnet KL: The origins of HLA-A,B,C polymorphism. Immunol Rev 1995; 143:141
38. Heemels MT, Ploegh H. Generation, translocation and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995;64:463.
39. O'Rourke AM, Mescher MF: The roles of CD8 in cytotoxic T lymphocyte function. Immunol Today 1993;14:183.
40. Salter RD, Norment AM, Chen BP, et al. Polymorphism in the α3 domain of HLA-A molecules affects binding to CDS. Nature 1989;338:345.
41. Trinchieri G: Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med 1994;180:417.
42. Yokoyama WM: Recognition structures on natural killer cells. Curr Opin Immunol 1993;5:67.
43. Yokoyama W, Kehn P, Cohen D, Shevach E: Chromosomal location of the Ly-49 multigene family J Immunol 1990;145:2353
44. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells Nature 1992;358:66
45. Yokoyama WM, Seaman WE: The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annu Rev Immunol 1993;11:613
46. D'Andrea A, Chang C, Bacon K, McClanahan T, Phillips JH, Lamer LL: Molecular cloning of NKB1: A natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306.
47. Colonna M, Samaridis J: Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405.
48. Wagtmann N, Biassoni R, Cantoni C, et al: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439.
49. Barber L, Parham P: Peptide binding to major histocompatibility complex molecules. Annu Rev Cell Biol 1993;9:163.
50. Bjorkman PJ, Parham P: Structure, function and diversity of class 1 major histocompatibility molecules Annu Rev Biochem 1990;59:253.
51. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL: Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993;260:1121.
52. Moretta A, Vitale M, Bottino C, et al: p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597.
53. Gumperz JE, Litwin V, Phillips JH, Lamer LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133
54. Wan AM, Ennis P, Parham P, Holmes N: The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol 1986;137:3671.
55. Falk K, Rotzschke O, Takiguchi M, et al: Peptide motifs of HLA-B58, B60, B61, and B62 molecules, Immunogenetics 1995;41:165.
56. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P: Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 1995;5:179.
57. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994;180:537.
58. Malnati MS, Peruzzi M, Parker KC, et al: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016.
59. Correa I, Raulet DH Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61.
60. Robey E, Fowlkes BJ: Selective events in T cell development. Annu Rev Immunol 1994;12:675.
61. Gumperz JE, Vahante NM, Parham P, Lanier LL, Tyan D: Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different HLA types appear genetically regulated, but not linked to MHC haplotype J Exp Med, in press.
62. Olsson M, Karre K, Sentman C: Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci USA 1995;92:1649.
63. Lanier LL, Gumperz J, Parham P, Melero I, Lopez-Botet M, Phillips JH. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995;154:3320.
64. Lanier LL, Phillips JH. Molecular and cell biology of inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86.
65. Sette A, Alexander J, Ruppert J, et al: Antigen analogs/MHC complexes as specific T cell receptor antagonists Annu Rev Immunol 1994;12:413.
66. Mueller DL, Jenkins MK: Molecular mechanisms underlying functional T-cell unresponsiveness Curr Opin Immunol 1995;7:375
67. Doody GM, Justement LB, Delibrias CC, et al: A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995;269:242.
68. D'Ambrosia D, Hippen KL, Minskoff SA, et al: Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 1995;268:293.
69. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994;12:555
70. Einspahr KJ, Abraham RT, Binstadt BA, Uehara Y, Leibson PJ. Tyrosine phosphorylation provides an early requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci USA 1991;23:6279.
71. Park DJ, Rho HW, Rhee SG: CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T cell line. Proc Natl Acad Sci USA 1991;88:5453.
72. Ting AT. Einspahr KJ, Abraham RT, Leibson PJ: Fc gamma receptor signal transduction in natural killer cells, coupling to phospholipase C via G protein-independent, but tyrosine kinase-dependent pathway. J Immunol 1991;147:3122
73. Kaufman DS Schoon RA, Robertson MJ, Leibson PJ: Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci USA 1995:92:6484.
74. Burshtyn DN, Scharenburg AM, Wagtmann N, et al: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77.
75. Moretta A, Sivori S, Vitale M, et al: Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995; 182:875.
76. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes Science 1995;268:403.
77. Biron CA, Byron KS, Sullivan JL Susceptibility to viral infections in an individual with a complete lack of natural killer cells. Nat Immun Cell Growth Regul 1988;7:47.
78. Fleisher G, Koven N, Kamiya H, Henle W: A non-X-linked syndrome with susceptibility to severe Epstein-Barr virus infections J Pediatr 1982;100:727.
79. Scott P, Trinchieri G: The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 1995;7:34.
80. Romagnani S: Induction of TH1 and TH2 responses: A key role for the natural immune response. Immunol Today 1992;13:379.
81. Scharton TM, Scott P: Natural killer cells are a source of interferon-gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major of mice. J Exp Med 1993; 178:567.